Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Darunavir Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Tablet
  • 1.4.3 Oral suspension
• 1.5 Market by Application
  • 1.5.1 Global Darunavir Market Share by Application (2014-2025)
  • 1.5.2 Hospital
  • 1.5.3 Drug store
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Darunavir Market Size
• 2.2 Darunavir Growth Trends by Regions
  • 2.2.1 Darunavir Market Size by Regions (2014-2025)
  • 2.2.2 Darunavir Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Darunavir Market Size by Manufacturers
  • 3.1.1 Global Darunavir Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Darunavir Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Darunavir Market Concentration Ratio (CR5 and HHI)
• 3.2 Darunavir Key Players Head office and Area Served
• 3.3 Key Players Darunavir Product/Solution/Service
• 3.4 Date of Enter into Darunavir Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Darunavir Market Size by Type (2014-2019)
• 4.2 Global Darunavir Market Size by Application (2014-2019)

5 United States

• 5.1 United States Darunavir Market Size (2014-2019)
• 5.2 Darunavir Key Players in United States
• 5.3 United States Darunavir Market Size by Type
• 5.4 United States Darunavir Market Size by Application

6 Europe

• 6.1 Europe Darunavir Market Size (2014-2019)
• 6.2 Darunavir Key Players in Europe
• 6.3 Europe Darunavir Market Size by Type
• 6.4 Europe Darunavir Market Size by Application

7 China

• 7.1 China Darunavir Market Size (2014-2019)
• 7.2 Darunavir Key Players in China
• 7.3 China Darunavir Market Size by Type
• 7.4 China Darunavir Market Size by Application

8 Japan

• 8.1 Japan Darunavir Market Size (2014-2019)
• 8.2 Darunavir Key Players in Japan
• 8.3 Japan Darunavir Market Size by Type
• 8.4 Japan Darunavir Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Darunavir Market Size (2014-2019)
• 9.2 Darunavir Key Players in Southeast Asia
• 9.3 Southeast Asia Darunavir Market Size by Type
• 9.4 Southeast Asia Darunavir Market Size by Application

10 India

• 10.1 India Darunavir Market Size (2014-2019)
• 10.2 Darunavir Key Players in India
• 10.3 India Darunavir Market Size by Type
• 10.4 India Darunavir Market Size by Application

11 Central & South America

• 11.1 Central & South America Darunavir Market Size (2014-2019)
• 11.2 Darunavir Key Players in Central & South America
• 11.3 Central & South America Darunavir Market Size by Type
• 11.4 Central & South America Darunavir Market Size by Application

12 International Players Profiles

• 12.1 Janssen Therapeutics
  • 12.1.1 Janssen Therapeutics Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Darunavir Introduction
  • 12.1.4 Janssen Therapeutics Revenue in Darunavir Business (2014-2019)
  • 12.1.5 Janssen Therapeutics Recent Development
• 12.2 Mylan
  • 12.2.1 Mylan Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Darunavir Introduction
  • 12.2.4 Mylan Revenue in Darunavir Business (2014-2019)
  • 12.2.5 Mylan Recent Development
• 12.3 Teva
  • 12.3.1 Teva Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Darunavir Introduction
  • 12.3.4 Teva Revenue in Darunavir Business (2014-2019)
  • 12.3.5 Teva Recent Development
• 12.4 Cipla
  • 12.4.1 Cipla Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Darunavir Introduction
  • 12.4.4 Cipla Revenue in Darunavir Business (2014-2019)
  • 12.4.5 Cipla Recent Development
• 12.5 Lupin
  • 12.5.1 Lupin Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Darunavir Introduction
  • 12.5.4 Lupin Revenue in Darunavir Business (2014-2019)
  • 12.5.5 Lupin Recent Development
• 12.6 Hetero
  • 12.6.1 Hetero Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Darunavir Introduction
  • 12.6.4 Hetero Revenue in Darunavir Business (2014-2019)
  • 12.6.5 Hetero Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Darunavir (DRV), sold under the brand name Prezista among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals.
In 2018, the global Darunavir market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Darunavir status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Darunavir development in United States, Europe and China.

The key players covered in this study
Janssen Therapeutics
Mylan
Teva
Cipla
Lupin
Hetero
...

Market segment by Type, the product can be split into
Tablet
Oral suspension

Market segment by Application, split into
Hospital
Drug store

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Darunavir status, future forecast, growth opportunity, key market and key players.
To present the Darunavir development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Darunavir are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.